Skip to content
Legacy Poker Central provides in-depth poker strategy guide…

Patients Stopping Slimming Injections Gain Back Weight Four Times Faster Than Dieters

Image of pharmaceutical syringe and weighing machine
Weight management involves ongoing approaches.

New research suggests that individuals who stop using new weight-loss injections like Mounjaro or Wegovy may regain reduced body mass at a significantly accelerated pace than those who stop conventional lifestyle plans.

Published data in a prominent health publication points out that while overweight people often shed substantial amounts of their body weight while on the medication, the mass returns at an estimated rate of nearly a kilo each month upon discontinuation.

"Individuals using such drugs should be cognizant of the danger of fast weight regain when the therapy ends," stated lead investigator Dr. Susan Jebb.

That rate of recovery suggests a return to starting mass in about 18 months.

Comparing Approaches

The study, which reviewed 37 of trials involving thousands of patients, compared the outcomes of GLP-1 agonists with conventional dieting.

The team note that people who lose weight through dieting generally experience a more gradual creep back—perhaps 100 grams monthly—post-intervention.

Explaining the Quick Rebound

Doctors suggest the way of the injections accounts for the heightened weight return.

These medications imitate a natural hormone called glucagon-like peptide-1, which controls appetite.

"Sustained high doses of GLP-1 concentrations far above than normal might result in the system to produce less of its own natural hormone, and could diminish responsiveness to its effects," explained Dr. Adam Collins, a nutrition expert.

"Stopping of this hormone supplement means hunger is uncontrolled, making binge eating far more likely."

An Ongoing Condition?

The NHS advise the injections for individuals with obesity-related health risks, alongside prescribed lifestyle changes.

A number of clinicians contend that, due to the likelihood of relapse, the treatment might need to be ongoing.

This perspective is supported by pharmaceutical companies, who say that the findings "highlight the persistent nature of obesity," similar to managing conditions like high blood pressure.

User Experiences

People who have come off the jabs explain a powerful resurgence of cravings.

"It was like something activating and you become extremely hungry," described one woman.

This challenge is worsened if users have not established permanent lifestyle or habit modifications during therapy.

Growing Use

Recent estimates indicate that a significant number of adults in the UK have used weight-loss jabs in the past year, with interest remaining high.

  • Adoption is higher among females compared to men.
  • The 40s and 50s age group shows the highest usage rates.
  • Many access the medications through private healthcare rather than public health services.

In conclusion, experts stress that while the jabs are effective tools for weight loss, they are not a magic fix and long-term success hinges on combined behavioural management.

Written by

Robert Bender

A professional poker player and analyst with over a decade of experience in high-stakes tournaments and strategy coaching.

Legacy Poker Central

Type to search articles.